New York School of Regional Anesthesia   Report issue

Academic/Hospital Phase 4
Founded: New York City NY United States (1994)

Organization Overview

First Clinical Trial
2015
NCT02554357
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Admir Hadzic, M.D., Ph.D. | New York School of Regional Anesthesia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carpal Tunnel Syndrome (Phase 4)

Contracture (Phase 2)

Dupuytren Contracture (Phase 2)

Hallux Valgus (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 3